Bactrim Dosing for Uncomplicated Cystitis in Dialysis Patients
Recommended Dosing Regimen
For an adult on chronic hemodialysis with uncomplicated cystitis, administer one double-strength Bactrim tablet (160 mg TMP/800 mg SMX) after each dialysis session, three times weekly. 1, 2
Key Dosing Principles
Post-dialysis timing is mandatory: Always give Bactrim immediately after completing the dialysis session, never before, as pre-dialysis dosing results in 44-57% drug removal during dialysis and leads to treatment failure. 3, 2
Do not reduce the individual dose size: Maintain the full double-strength tablet per dose but extend the interval to three times weekly rather than daily dosing. 1, 2
Avoid standard renal dosing charts: These apply only to non-dialysis chronic kidney disease patients and will result in underdosing in dialysis patients who require supplementation after each session due to dialytic drug removal. 1, 4
Treatment Duration
Standard 7-day equivalent: Since dialysis patients receive medication three times weekly, continue treatment for 2-3 weeks (6-9 doses total) to approximate the standard 7-day course recommended for uncomplicated cystitis in non-dialysis patients. 5
The European Association of Urology guidelines recommend 7 days of TMP-SMX (160/800 mg twice daily) for uncomplicated cystitis in men, which translates to approximately 2-3 weeks of thrice-weekly post-dialysis dosing. 5
Alternative Dosing Options
If using single-strength tablets (80 mg TMP/400 mg SMX):
- Give two single-strength tablets after each dialysis session, three times weekly. 2
Pharmacokinetic Rationale
Hemodialysis removes approximately 44% of trimethoprim and 57% of sulfamethoxazole during a 4-hour session, with dialysis clearances of 38 ml/min and 42 ml/min respectively. 3
The elimination half-life during dialysis is 6.0 hours for TMP and 3.1 hours for SMX, necessitating post-dialysis supplementation. 3
Critical Pitfalls to Avoid
Never dose daily: The three-times-weekly post-dialysis schedule aligns with drug clearance patterns and prevents accumulation toxicity. 1, 2
Never give before dialysis: This wastes medication and leaves the patient undertreated. 2, 4
Do not use prophylactic dosing for active infection: Prophylactic regimens (half-dose or one single-strength tablet post-dialysis) are inadequate for treating active cystitis. 1, 2
Monitoring and Safety
Watch for drug interactions: TMP-SMX potentiates warfarin anticoagulation and may interact with antidiabetic agents. 2, 4
Monitor hematologic toxicity: Obtain CBC with differential at baseline and monthly during treatment. 4
Fluid intake: Encourage adequate hydration in patients with residual urine output to minimize crystalluria risk, though this is less concerning in anuric dialysis patients. 2, 4
Special Considerations for Peritoneal Dialysis
If the patient is on peritoneal dialysis (CAPD) rather than hemodialysis: